References
- Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and −2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol. 1998;141(7):1–11. doi:https://doi.org/10.1083/jcb.141.7.1539.
- Furuse M, Sasaki H, Fujimoto K, Tsukita S. A single gene product, claudin-1 or −2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol. 1998;143(2):391–401. doi:https://doi.org/10.1083/jcb.143.2.391.
- Furuse M, Tsukita S. Claudins in occluding junctions of humans and flies. Trends Cell Biol. 2006;16(4):181–188. doi:https://doi.org/10.1016/j.tcb.2006.02.006.
- Van Itallie CM, Anderson JM. Claudins and epithelial paracellular transport. Annu Rev Physiol. 2006;68(1):403–429. doi:https://doi.org/10.1146/annurev.physiol.68.040104.131404.
- Chiba H, Osanai M, Murata M, Kojima T, Sawada N. Transmembrane proteins of tight junctions. Biochim Biophys Acta. 2008;1778(3):588–600. doi:https://doi.org/10.1016/j.bbamem.2007.08.017.
- Zihni C, Mills C, Matter K, Balda MS. Tight junctions: from simple barriers to multifunctional molecular gates. Nat Rev Mol Cell Biol. 2016;17(9):564–580. doi:https://doi.org/10.1038/nrm.2016.80.
- Tsukita S, Tanaka H, Tamura TA. The claudins: from tight junctions to biological systems. Trends Biochem Sci. 2019;44(2):141–152. doi:https://doi.org/10.1016/j.tibs.2018.09.008.
- Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. Structure and function of claudins. Biochim Biophys Acta. 2008;1778(3):631–645. doi:https://doi.org/10.1016/j.bbamem.2007.10.018.
- Piontek J, Winkler L, Wolburg H, Müller SL, Zuleger N, Piehl C, Wiesner B, Krause G, Blasig IE. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J. 2008;22(1):146–158. doi:https://doi.org/10.1096/fj.07-8319com.
- Suzuki H, Nishizawa T, Tani K, Yamazaki Y, Tamura A, Ishitani R, Dohmae N, Tsukita S, Nureki O, Fujiyoshi Y. Crystal structure of a claudin provides insight into the architecture of tight junctions. Science. 2014;344(6181):304–307. doi:https://doi.org/10.1126/science.1248571.
- Haseloff RF, Piontek J, Blasig IE. Chapter 5 – the investigation of cis- and trans-interactions between claudins. In: Yu AS L editor. Current topics in membranes. Academic Press, USA; 2010. p. 97–112.
- Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol. 1999;147(6):1351–1363. doi:https://doi.org/10.1083/jcb.147.6.1351.
- Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001;2(4):285–293. doi:https://doi.org/10.1038/35067088.
- González-Mariscal L, Garay E, Quirós M. Chapter 6 – regulation of claudins by posttranslational modifications and cell-signaling cascades. In: Yu AS L editor. Current topics in membranes. Academic Press, USA; 2010. p. 113–150.
- Van Itallie CM, Anderson JM. Phosphorylation of tight junction transmembrane proteins: many sites, much to do. Tissue Barriers. 2018;6(1):e1382671. doi:https://doi.org/10.1080/21688370.2017.1382671.
- Tabariès S, McNulty A, Ouellet V, Annis MG, Dessureault M, Vinette M, Hachem Y, Lavoie B, Omeroglu A, Simon H-G, et al. Afadin cooperates with claudin-2 to promote breast cancer metastasis. Genes Dev. 2019;33(3–4):180–193. doi:https://doi.org/10.1101/gad.319194.118.
- Cavallaro U, Dejana E. Adhesion molecule signalling: not always a sticky business. Nat Rev Mol Cell Biol. 2011;12(3):189–197. doi:https://doi.org/10.1038/nrm3068.
- Günzel D, Yu ASL. Claudins and the modulation of tight junction permeability. Physiol Rev. 2013;93(2):525–569. doi:https://doi.org/10.1152/physrev.00019.2012.
- Sawada N. Tight junction-related human diseases. Pathol Int. 2013;63(1):1–12. doi:https://doi.org/10.1111/pin.12021.
- Barmeyer C, Schulzke JD, Fromm M. Claudin-related intestinal diseases. Semin Cell Dev Biol. 2015;42:30–38. doi:https://doi.org/10.1016/j.semcdb.2015.05.006.
- Tawar RG, Colpitts CC, Lupberger J, El-Saghire H, Zeisel MB, Baumert TF. Claudins and pathogenesis of viral infection. Semin Cell Dev Biol. 2015;42:39–46. doi:https://doi.org/10.1016/j.semcdb.2015.04.011.
- Zeisel MB, Dhawan P, Baumert TF. Tight junction proteins in gastrointestinal and liver disease. Gut. 2019;68(3):547–561. doi:https://doi.org/10.1136/gutjnl-2018-316906.
- Culemann S, Grüneboom A, Nicolás-Ávila JÁ, Weidner D, Lämmle KF, Rothe T, Quintana JA, Kirchner P, Krljanac B, Eberhardt M, et al. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature. 2019;572(7771):670–675. doi:https://doi.org/10.1038/s41586-019-1471-1.
- Zhu Z, Yu J, Lin W, Tang H, Zhang W, Lu B. Molecular hydrogen accelerates the reversal of acute obstructive cholangitis‑induced liver dysfunction by restoring gap and tight junctions. Mol Med Rep. 2019;19(6):5177–5184. doi:https://doi.org/10.3892/mmr.2019.10179.
- Zuo L, Kuo W-T, Turner JR. Tight junctions as targets and effectors of mucosal immune homeostasis. Cell Mol Gastroenterol Hepatol. 2020;10(2):327–340. doi:https://doi.org/10.1016/j.jcmgh.2020.04.001.
- Oliveira SS, Morgado-Díaz JA. Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci. 2007;64(1):17–28. doi:https://doi.org/10.1007/s00018-006-6314-1.
- Valle BL, Morin PJ. Chapter 13 – claudins in cancer biology. In: Yu AS L editor. Current topics in membranes. Academic Press, United States; 2010. p. 293–333.
- Turksen K, Troy T-C. Junctions gone bad: claudins and loss of the barrier in cancer. Biochim Biophys Acta. 2011;1816(1):73–79. doi:https://doi.org/10.1016/j.bbcan.2011.04.001.
- Osanai M, Takasawa A, Murata M, Sawada N. Claudins in cancer: bench to bedside. Pflugers Arch. 2017;469(1):55–67. doi:https://doi.org/10.1007/s00424-016-1877-7.
- Tabariès S, Siegel PM. The role of claudins in cancer metastasis. Oncogene. 2017;36(9):1176–1190. doi:https://doi.org/10.1038/onc.2016.289.
- Gowrikumar S, Singh AB, Dhawan P. Role of claudin proteins in regulating cancer stem cells and chemoresistance-potential implication in disease prognosis and therapy. Int J Mol Sci. 2019;21(1):53. doi:https://doi.org/10.3390/ijms21010053.
- Bhat AA, Syed N, Therachiyil L, Nisar S, Hashem S, Macha MA, Yadav SK, Krishnankutty R, Muralitharan S, Al-Naemi H, et al. Claudin-1, a double-edged sword in cancer. Int J Mol Sci. 2020;21(2):569. Available from: http://dx.doi.org/10.3390/ijms21020569.
- Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, Takahashi A, Flanigan ME, Aleyasin H, LeClair KB, et al. Social stress induces neurovascular pathology promoting depression. Nat Neurosci. 2017;20(12):1752–1760. doi:https://doi.org/10.1038/s41593-017-0010-3.
- Nishiura K, Ichikawa-Tomikawa N, Sugimoto K, Kunii Y, Kashiwagi K, Tanaka M, Yokoyama Y, Hino M, Sugino T, Yabe H, et al. PKA activation and endothelial claudin-5 breakdown in the schizophrenic prefrontal cortex. Oncotarget. 2017;8(55):93382–93391. doi:https://doi.org/10.18632/oncotarget.21850.
- Greene C, Campbell M. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers. 2016;4(1):e1138017. doi:https://doi.org/10.1080/21688370.2015.1138017.
- Yamazaki Y, Shinohara M, Shinohara M, Yamazaki A, Murray ME, Liesinger AM, Heckman MG, Lesser ER, Parisi JE, Petersen RC, et al. Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression. Brain. 2019;142(4):1077–1092. doi:https://doi.org/10.1093/brain/awz011.
- Niu J, Tsai H-H, Hoi KK, Huang N, Yu G, Kim K, Baranzini SE, Xiao L, Chan JR, Fancy SPJ. Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier, triggering CNS inflammation. Nat Neurosci. 2019;22(5):709–718. doi:https://doi.org/10.1038/s41593-019-0369-4.
- Dudek KA, Dion-Albert L, Lebel M, LeClair K, Labrecque S, Tuck E, Ferrer Perez C, Golden SA, Tamminga C, Turecki G, et al. Molecular adaptations of the blood-brain barrier promote stress resilience vs. Depression Proc Natl Acad Sci U S A. 2020;117(6):3326–3336. doi:https://doi.org/10.1073/pnas.1914655117.
- Greene C, Hanley N, Campbell M. Blood-brain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders. Transl Psychiatry. 2020;10(1):373. doi:https://doi.org/10.1038/s41398-020-01054-3.
- Greene C, Hanley N, Campbell M. Claudin-5: gatekeeper of neurological function. Fluids Barriers CNS. 2019;16(1):3. doi:https://doi.org/10.1186/s12987-019-0123-z.
- Chiba H, Ichikawa-Tomikawa N, Imura T, Sugimoto K. The region-selective regulation of endothelial claudin-5 expression and signaling in brain health and disorders. J Cell Physiol. 2021. Available from https://doi.org/10.1002/jcp.30357
- Spadaro D, Le S, Laroche T, Mean I, Jond L, Yan J, Citi S. Tension-dependent stretching activates ZO-1 to control the junctional localization of its interactors. Curr Biol. 2017;27(3783–3795.e8):3783–3795.e8. doi:https://doi.org/10.1016/j.cub.2017.11.014.
- Zenker J, White MD, Gasnier M, Alvarez YD, Lim HYG, Bissiere S, Biro M, Plachta N. Expanding actin rings zipper the mouse embryo for blastocyst formation. Cell. 2018;173(3):776–791.e17. doi:https://doi.org/10.1016/j.cell.2018.02.035.
- Bendriem RM, Singh S, Aleem AA, Antonetti DA, Ross ME. Tight junction protein occludin regulates progenitor self-renewal and survival in developing cortex. Elife. 2019;8:664. doi:https://doi.org/10.7554/eLife.49376.
- Beutel O, Maraspini R, Pombo-García K, Martin-Lemaitre C, Honigmann A. Phase separation of zonula occludens proteins drives formation of tight junctions. Cell. 2019;179(4):923–936.e11. doi:https://doi.org/10.1016/j.cell.2019.10.011.
- Kuo W-T, Shen L, Zuo L, Shashikanth N, Ong MLDM, Wu L, Zha J, Edelblum KL, Wang Y, Wang Y, et al. Inflammation-induced occludin downregulation limits epithelial apoptosis by suppressing caspase-3 expression. Gastroenterology. 2019;157(5):1323–1337. doi:https://doi.org/10.1053/j.gastro.2019.07.058.
- Otani T, Nguyen TP, Tokuda S, Sugihara K, Sugawara T, Furuse K, Miura T, Ebnet K, Furuse FM. Claudins and JAM-A coordinately regulate tight junction formation and epithelial polarity. J Cell Biol. 2019;218(10):3372–3396. doi:https://doi.org/10.1083/jcb.201812157.
- Schwayer C, Shamipour S, Pranjic-Ferscha K, Schauer A, Balda M, Tada M, Matter K, Heisenberg C-P. Mechanosensation of tight junctions depends on ZO-1 phase separation and flow. Cell. 2019;179(4):937–952.e18. doi:https://doi.org/10.1016/j.cell.2019.10.006.
- Barnat M, Capizzi M, Aparicio E, Boluda S, Wennagel D, Kacher R, Kassem R, Lenoir S, Agasse F, Braz BY, et al. Huntington’s disease alters human neurodevelopment. Science. 2020;369(6505):787–793. doi:https://doi.org/10.1126/science.aax3338.
- Belardi B, Hamkins-Indik T, Harris AR, Kim J, Xu K, Fletcher DA, Weak A. Link with actin organizes tight junctions to control epithelial permeability. Dev Cell. 2020;54(792–804.e7):792–804.e7. doi:https://doi.org/10.1016/j.devcel.2020.07.022.
- Citi S. Cell Biology: Tight junctions as biomolecular condensates. Curr Biol. 2020;30(2):R83–6. doi:https://doi.org/10.1016/j.cub.2019.11.060.
- Hartmann C, Schwietzer YA, Otani T, Furuse M, Ebnet K. Physiological functions of junctional adhesion molecules (JAMs) in tight junctions. Biochim Biophys Acta. 2020;1862(9):183299. doi:https://doi.org/10.1016/j.bbamem.2020.183299.
- Lauko A, Mu Z, Gutmann DH, Naik UP, Lathia JD. Junctional adhesion molecules in cancer: a paradigm for the diverse functions of cell-cell interactions in tumor progression. Cancer Res. 2020;80(22):4878–4885. doi:https://doi.org/10.1158/0008-5472.CAN-20-1829.
- Otani T, Furuse M. Tight junction structure and function revisited. Trends Cell Biol. 2020;30(10):805–817. doi:https://doi.org/10.1016/j.tcb.2020.08.004.
- Zhou T, Lu Y, Xu C, Wang R, Zhang L, Lu P. Occludin protects secretory cells from ER stress by facilitating SNARE-dependent apical protein exocytosis. Proc Natl Acad Sci U S A. 2020;117(9):4758–4769. doi:https://doi.org/10.1073/pnas.1909731117.
- Kubota H, Chiba H, Takakuwa Y, Osanai M, Tobioka H, Kohama G, Mori M, Retinoid SN. X receptor alpha and retinoic acid receptor gamma mediate expression of genes encoding tight-junction proteins and barrier function in F9 cells during visceral endodermal differentiation. Exp Cell Res. 2001;263(1):163–172. doi:https://doi.org/10.1006/excr.2000.5113.
- Chiba H, Gotoh T, Kojima T, Satohisa S, Kikuchi K, Osanai M, Sawada N. Hepatocyte nuclear factor (HNF)-4alpha triggers formation of functional tight junctions and establishment of polarized epithelial morphology in F9 embryonal carcinoma cells. Exp Cell Res. 2003;286(2):288–297. doi:https://doi.org/10.1016/S0014-4827(03)00116-2.
- Satohisa S, Chiba H, Osanai M, Ohno S, Kojima T, Saito T, Sawada N. Behavior of tight-junction, adherens-junction and cell polarity proteins during HNF-4alpha-induced epithelial polarization. Exp Cell Res. 2005;310(1):66–78. doi:https://doi.org/10.1016/j.yexcr.2005.06.025.
- Chiba H, Sakai N, Murata M, Osanai M, Ninomiya T, Kojima T, Sawada N. The nuclear receptor hepatocyte nuclear factor 4alpha acts as a morphogen to induce the formation of microvilli. J Cell Biol. 2006;175(6):971–980. doi:https://doi.org/10.1083/jcb.200608012.
- Sugimoto K, Ichikawa-Tomikawa N, Satohisa S, Akashi Y, Kanai R, Saito T, Sawada N, Chiba H. The tight-junction protein claudin-6 induces epithelial differentiation from mouse F9 and embryonic stem cells. PLoS One. 2013;8(10):e75106. doi:https://doi.org/10.1371/journal.pone.0075106.
- Sugimoto K, Ichikawa-Tomikawa N, Kashiwagi K, Endo C, Tanaka S, Sawada N, Watabe T, Higashi T, Chiba H. Cell adhesion signals regulate the nuclear receptor activity. Proc Natl Acad Sci U S A. 2019;116(49):24600–24609. doi:https://doi.org/10.1073/pnas.1913346116.
- Li C-F, Chen J-Y, Ho Y-H, Hsu W-H, Wu L-C, Lan H-Y, Hsu D-S-S, Tai S-K, Chang Y-C, Yang M-H. Snail-induced claudin-11 prompts collective migration for tumour progression. Nat Cell Biol. 2019;21(2):251–262. doi:https://doi.org/10.1038/s41556-018-0268-z.
- Singh AB, Sharma A, Dhawan P. Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner. Carcinogenesis. 2012;33(12):2538–2547. doi:https://doi.org/10.1093/carcin/bgs275.
- Huang H, Li L, Wu C, Schibli D, Colwill K, Ma S, Li C, Roy P, Ho K, Songyang Z, et al. Defining the specificity space of the human SRC homology 2 domain. Mol Cell Proteomics. 2008;7(4):768–784. doi:https://doi.org/10.1074/mcp.M700312-MCP200.
- Filippakopoulos P, Müller S, Knapp S. SH2 domains: modulators of nonreceptor tyrosine kinase activity. Curr Opin Struct Biol. 2009;19(6):643–649. doi:https://doi.org/10.1016/j.sbi.2009.10.001.
- Liu BA, Engelmann BW, Jablonowski K, Higginbotham K, Stergachis AB, Nash PD. SRC homology 2 domain binding sites in insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome. Cell Commun Signal. 2012;10(1):27. doi:https://doi.org/10.1186/1478-811X-10-27.
- Mayer BJ. The discovery of modular binding domains: building blocks of cell signalling. Nat Rev Mol Cell Biol. 2015;16(11):691–698. doi:https://doi.org/10.1038/nrm4068.
- Shimobaba S, Taga S, Akizuki R, Hichino A, Endo S, Matsunaga T, Watanabe R, Yamaguchi M, Yamazaki Y, Sugatani J, et al. Claudin-18 inhibits cell proliferation and motility mediated by inhibition of phosphorylation of PDK1 and Akt in human lung adenocarcinoma A549 cells. Biochim Biophys Acta. 2016;1863(6):1170–1178. doi:https://doi.org/10.1016/j.bbamcr.2016.02.015.
- Luo J, Chimge N-O, Zhou B, Flodby P, Castaldi A, Firth AL, Liu Y, Wang H, Yang C, Marconett CN, et al. CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro. Int J Cancer. 2018;143(12):3169–3180. doi:https://doi.org/10.1002/ijc.31734.
- Brunton VG, Irj M, Frame MC. Cell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitry. Biochim Biophys Acta. 2004;1692(2–3):121–144. doi:https://doi.org/10.1016/j.bbamcr.2004.04.010.
- McLachlan RW, Kraemer A, Helwani FM, Kovacs EM, Yap AS, Mostov K. E-cadherin adhesion activates c-Src signaling at cell-cell contacts. Mol Biol Cell. 2007;18(8):3214–3223. doi:https://doi.org/10.1091/mbc.e06-12-1154.
- Cabodi S, Di Stefano P, Leal M, Del Pc TA, Bisaro B, Morello V, Damiano L, Aramu S, Repetto D, Tornillo G, et al. Integrins and signal transduction. Adv Exp Med Biol. 2010;674:43–54.
- Canel M, Serrels A, Frame MC, Brunton VG. E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci. 2013;126(2):393–401. doi:https://doi.org/10.1242/jcs.100115.
- Xiao R, Xi X-D, Chen Z, Chen S-J S-J, Meng G. Structural framework of c-Src activation by integrin β3. Blood. 2013;121(4):700–706. doi:https://doi.org/10.1182/blood-2012-07-440644.
- Ochs K, Málaga-Trillo E. Common themes in PrP signaling: the Src remains the same. Front Cell Dev Biol. 2014;2:63. doi:https://doi.org/10.3389/fcell.2014.00063.
- Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18(9):533–548. doi:https://doi.org/10.1038/s41568-018-0038-z.
- Witherden DA, Verdino P, Rieder SE, Garijo O, Mills RE, Teyton L, Fischer WH, Wilson IA, Havran WL. The junctional adhesion molecule JAML is a costimulatory receptor for epithelial gammadelta T cell activation. Science. 2010;329(5996):1205–1210. doi:https://doi.org/10.1126/science.1192698.
- Yaffe MB. MAGUK SH3 domains–swapped and stranded by their kinases? Structure. 2002;10(1):3–5. doi:https://doi.org/10.1016/S0969-2126(01)00705-5.
- Lim WA, Pawson T. Phosphotyrosine signaling: evolving a new cellular communication system. Cell. 2010;142(5):661–667. doi:https://doi.org/10.1016/j.cell.2010.08.023.
- Liu BA, Nash PD. Evolution of SH2 domains and phosphotyrosine signalling networks. Philos Trans R Soc Lond B Biol Sci. 2012;367(1602):2556–2573. doi:https://doi.org/10.1098/rstb.2012.0107.
- Wagner MJ, Stacey MM, Liu BA, Pawson T. Molecular mechanisms of SH2- and PTB-domain-containing proteins in receptor tyrosine kinase signaling. Cold Spring Harb Perspect Biol. 2013;5(12):a008987. doi:https://doi.org/10.1101/cshperspect.a008987.
- Kojima M, Sugimoto K, Tanaka M, Endo Y, Kato H, Honda T, Furukawa S, Nishiyama H, Watanabe T, Soeda S, et al. Prognostic significance of aberrant claudin-6 expression in endometrial cancer. Cancers. 2020;12(10):2748. Available from: http://dx.doi.org/10.3390/cancers12102748.
- Kojima M, Sugimoto K, Kobayashi M, Ichikawa-Tomikawa N, Kashiwagi K, Watanabe T, Soeda S, Fujimori K, Chiba H. Aberrant claudin-6-adhesion signaling promotes endometrial cancer progression via estrogen receptor α. Mol Cancer Res [ in press; Available from]. 2021. https://mcr.aacrjournals.org/content/early/2021/03/16/1541-7786.MCR-20-0835
- Lang F, Böhmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev. 2006;86(4):1151–1178. doi:https://doi.org/10.1152/physrev.00050.2005.
- Hagen SJ, Ang L-H, Zheng Y, Karahan SN, Wu J, Wang YE, Caron TJ, Gad AP, Muthupalani S, Fox JG. Loss of tight junction protein claudin 18 promotes progressive neoplasia development in mouse stomach. Gastroenterology. 2018;155(6):1852–1867. doi:https://doi.org/10.1053/j.gastro.2018.08.041.
- Zhou B, Flodby P, Luo J, Castillo DR, Liu Y, Yu F-X, McConnell A, Varghese B, Li G, Chimge N-O, et al. Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis. J Clin Invest. 2018;128(3):970–984. doi:https://doi.org/10.1172/JCI90429.
- Suzuki K, Sentani K, Tanaka H, Yano T, Suzuki K, Oshima M, Yasui W, Tamura A, Tsukita S. Deficiency of stomach-type claudin-18 in mice induces gastric tumor formation independent of H pylori infection. Cell Mol Gastroenterol Hepatol. 2019;8(1):119–142. doi:https://doi.org/10.1016/j.jcmgh.2019.03.003.
- Paquet-Fifield S, Koh SL, Cheng L, Beyit LM, Shembrey C, Mølck C, Behrenbruch C, Papin M, Gironella M, Guelfi S, et al. Tight junction protein claudin-2 promotes self-renewal of human colorectal cancer stem-like cells. Cancer Res. 2018;78(11):2925–2938. doi:https://doi.org/10.1158/0008-5472.CAN-17-1869.